Vaccine Stockpile Strategy Cost Implications Should Be Considered – NVAC
Executive Summary
The cost implications for vaccine storage strategies need to be considered in developing a national stockpile, National Immunization Program Director Walter Orenstein, MD, told a National Vaccine Advisory Committee workgroup April 1
You may also be interested in...
FDA Evaluating Vaccine GMP Requirements To Assess Impact on Supply
FDA is re-evaluating its approach to good manufacturing practices, FDA Acting Commissioner Lester Crawford, PhD, suggested during a June 12 hearing on vaccine supply
FDA Evaluating Vaccine GMP Requirements To Assess Impact on Supply
FDA is re-evaluating its approach to good manufacturing practices, FDA Acting Commissioner Lester Crawford, PhD, suggested during a June 12 hearing on vaccine supply
Vaccine GMP Reevaluation Needed, NVAC Draft Report On Shortages Says
Good manufacturing practices for vaccines should be reevaluated in light of recent vaccine shortages, according to a National Vaccine Advisory Committee draft report